Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00926536 · ClinicalTrials.gov registry record · NA
Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging Guidance
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT00926536: Completed NA study, sponsored by Stanford University.
NCT00926536 is a NA study that has completed, run by Stanford University. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00926536, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
Patients will be enrolled based on presence of HCC and eligibility for TACE. They will be randomized to one of two arms for imaging navigation to the optimal catheter location for chemotherapy injection to treat the first (possibly sole) tumor target. The two arms will be: TACE using C-arm CT supplemented by DSA or DSA only (only DSA images will be used for navigation and tumor vessel tracking). Navigation to subsequent treatment targets in all patients will be done with fluoroscopy, CACT, and DSA, as is standard of care at Stanford University Medical Center, and is not part of the study. Vascular complexity, which affects navigation difficulty and thus the need for imaging, will be assessed separately for use in data analysis by two radiologists on a four-point scale.
Interventions
- DEVICE C-arm CT + DSA as needed
- DEVICE DSA only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2009-04 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00926536
The ClinicalTrials.gov registry entry for NCT00926536 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which C-arm CT + DSA as needed is the first listed.
NCT00926536 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00926536 about?
NCT00926536 is a clinical study titled "Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging Guidance". Patients will be enrolled based on presence of HCC and eligibility for TACE. They will be randomized to one of two arms for imaging navigation to the optimal catheter location for chemotherapy injection to treat the first (possibly sole) tumor target. The two arms will be: TACE using C-arm CT supple...
What is the current status of trial NCT00926536?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2009-04. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00926536?
The interventions under investigation include: C-arm CT + DSA as needed (DEVICE), DSA only (DEVICE).
Who is sponsoring clinical trial NCT00926536?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.